New risk gene discovery gives hope to early-onset breast cancer sufferers

A new breast cancer risk gene has been discovered which explains the early-onset breast cancer in some multiple-case breast cancer families.

The international team of investigators led by the University of Melbourne Australia, identified in the RINT1 gene to increase risk of breast and many other cancers.

Professor Melissa Southey and Dr Daniel Park from the University's Department of Pathology presented the research today at the American Society of Human Genetics 2013 annual meeting in Boston.

Other researchers in this international team are from the Institute Curie in Paris, the International Agency for Research on Cancer in Lyon, France, and the Huntsman Cancer Institute in Salt Lake City, Utah.

Professor Southey said "this discovery will assist some more women learn the genetic explanation for their breast cancer risk and which of their family members are at high risk of developing cancer.   Currently only about 35 per cent of the familial risk for breast cancer has been explained."

Co-researcher Dr Park, Senior Research Fellow said "although mutations in RINT1 are rare, it is most likely that the remaining unknown breast will account for similar small proportions of the disease."

Rare mutations in RINT1 were identified in three of 49 families participating in a multiple-case breast cancer family study. The study applied the latest technology to search for unidentified breast genes.  

The researchers then assessed the association between RINT1 mutations and by conducting a population-based case-control study that identified 23 mutation carriers in a sample of 1,313 women diagnosed with early-onset breast cancer and only 6 mutation carriers in 1,123 unaffected women, demonstrating a significant association between mutations in RINT1 and risk of early onset breast cancer.

Further research included testing an additional 684 affected women from multiple-case breast cancer families for RINT1 mutations and six additional families were found to carry in RINT1.

This demonstration of RINT1 as a cancer susceptibility gene is consistent with prior literature that has described mice that carry a rint1 mutation spontaneously develop a variety of tumors including breast cancer, at a combined rate of 81 per cent, higher than the rate at which spontaneously develops in laboratory mice that have a brca1 mutation.

Related Stories

Recommended for you

Detecting skin cancer quickly

date 3 hours ago

Melanoma is aggressive and life-threatening. If it is not detected early, the prospects of recovery drop. Screening is complicated, though. Together with several project partners, Fraunhofer researchers have ...

Study finds new potential melanoma drug target

date May 02, 2015

A new treatment for melanoma could be on the horizon, thanks to a finding by a UNC Lineberger Comprehensive Cancer Center-led team. In the study, which was published online today in the journal Clinical Ca ...

Surgery for terminal cancer patients still common

date May 02, 2015

The number of surgeries performed on terminally ill cancer patients has not dropped in recent years, despite more attention to the importance of less invasive care for these patients to relieve symptoms and ...

Study provides comprehensive look at brain cancer treatments

date May 01, 2015

Led by the Translational Genomics Research Institute (TGen) and UC San Francisco (UCSF), a comprehensive genetic review of treatment strategies for glioblastoma brain tumors was published today in the Oxford University Press ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.